borderline significantp=0.050
This finding was consistent in sensitivity analysis (SMD ranged from 0.09 to 0.29), although exclusion of the UC subgroup from the Patel study ( 42 ) resulted in a borderline significant difference favoring higher sVCAM-1 levels in the active disease group (SMD 0.29, 95% CI –0.001 to 0.58, p=0.050).